Howard Liang
CIK: 0001663427
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BBTX
Bambusa Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Liang Howard
Liang Howard (SEC CIK 0001663427) files insider reports with the SEC as Director of Bambusa Therapeutics, Inc. (BBTX).
Signal8 holds 1 ownership filing by Liang Howard, a Form 3, filed on Oct 29, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Liang Howard's filings is in BOSTON, MA.
Other insiders filing for Bambusa Therapeutics, Inc. (BBTX)
- Salvia Investment GmbH, 10% Owner
- Jeggle Helmut Wolfgang, Director
- Xu Shanshan
- RA CAPITAL MANAGEMENT, L.P., Director
- DiRocco Derek, Director
- Foerster Christian Uwe, Director